Neuronetics (STIM) Net Income towards Common Stockholders (2017 - 2026)

Neuronetics (STIM) has reported Net Income towards Common Stockholders for 10 consecutive years, with -$11.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 13.96% year-over-year to -$11.3 million; the TTM figure through Mar 2026 stood at -$49.0 million (down 4.21% YoY), while the FY2025 annual figure was -$39.9 million, up 76.36% from the prior year.
• Net Income towards Common Stockholders fell to -$11.3 million in Q1 2026 per STIM's latest filing, from -$7.4 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at -$6.1 million in Q4 2023 and bottomed at -$18.2 million in Q2 2025.
• Historically, Net Income towards Common Stockholders has averaged -$10.8 million across 5 years, with a median of -$10.6 million in 2024.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders jumped 56.22% — and 2024, when it slumped 127.29%.
• Neuronetics' Net Income towards Common Stockholders stood at -$8.8 million in 2022, then jumped by 30.93% to -$6.1 million in 2023, then tumbled by 127.29% to -$13.9 million in 2024, then surged by 46.36% to -$7.4 million in 2025, then tumbled by 51.48% to -$11.3 million in 2026.
• Business Quant data shows STIM's Net Income towards Common Stockholders at -$11.3 million in Q1 2026, -$7.4 million in Q4 2025, and -$12.1 million in Q3 2025.